Εμφανίζονται 1 - 18 Αποτελέσματα από 18 για την αναζήτηση '"видеоэлектроэнцефалографический мониторинг"', χρόνος αναζήτησης: 0,79δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Vol 19, No 3 (2024); 68-77 ; Русский журнал детской неврологии; Vol 19, No 3 (2024); 68-77 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  2. 2
    Academic Journal

    Συγγραφείς: Bobylova M.Y., Abramov M.O., Mukhin K.Y.

    Πηγή: Russian Journal of Child Neurology; Vol 19, No 2 (2024); 49-63 ; Русский журнал детской неврологии; Vol 19, No 2 (2024); 49-63 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  3. 3
    Academic Journal
  4. 4
  5. 5
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 17, № 3 (2022); 55-62 ; Русский журнал детской неврологии; Том 17, № 3 (2022); 55-62 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2022-17-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/406/279; Абатуров А.Е., Петренко Л.Л., Кривуша Е.Л. Синдром Ангельмана. Часть 2 (клиника и диагностика). Здоровье ребенка 2015;6(66):119–25.; Кузьмич Г.В., Бобылова М.Ю., Мухин К.Ю. и др. ЭЭГ при синдроме Ангельмана. Зубчатые медленные волны и возрастные характеристики основных ЭЭГ-паттернов. Русский журнал детской неврологии 2021;16(1–2):42–57.; Михайлова Н.В., Савинов С.В., Акчурина Я.Е. и др. Синдром Ангельмана как иллюстрация дифференцированного подхода к диагностике причин аутизма, задержки психомоторного развития и ДЦП. Нейрохирургия и неврология Казахстана 2017;1(46):60–4.; Allen K.D., Kuhn B.R., DeHaai K.A., Wallace D.P. Evaluation of a behavioral treatment package to reduce sleep problems in children with Angelman syndrome. Res Dev Disabil 2013;34(1):676–86. DOI:10.1016/j.ridd.2012.10.001; Braam W., Didden R., Smits M.G., Curfs L.M. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebocontrolled trial. J Child Neurol 2008;23(6):649–54. DOI:10.1177/0883073808314153; Bruni O., Cortesi F., Giannotti F., Curatolo P. Sleep disorders in tuberous sclerosis: a polysomnographic study. Brain Dev 1995;17(1):52–6.; Conant K.D., Thibert R.L., Thiele E.A. Epilepsy and the sleepwake patterns found in Angelman syndrome. Epilepsia 2009;50(11):2497–500. DOI:10.1111/j.1528-1167.2009.02109.x; Dagli A., Mathews J., Williams Ch. Angelman Syndrome. In: GeneReviews®. Seattle: University of Washington, 1993–2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1144/; Dan B., Boyd S.G. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis. Neuropediatrics 2003;34(4):169–76. DOI:10.1055/s-2003-42213; Den Bakker H., Sidorov M.S., Fan Z. et al. Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study. Mol Autism 2018;9:32. DOI:10.1186/s13229-018-0214-8; Durmer J.S., Dinges D.F. Neurocognitive consequences of sleep deprivation. Semin Neurol 2005;25(1):117–29. DOI:10.1055/s-2005-867080; Ehlen J.C., Jones K.A., Pinckney L. et al. Maternal Ube3a loss disrupts sleep homeostasis but leaves circadian rhythmicity largely intact. J Neurosci 2015;35(40):13587–98. DOI:10.1523/JNEUROSCI.2194-15.2015; Gossan N.C., Zhang F., Guo B. et al. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res 2014;42(9):5765–75. DOI:10.1093/nar/gku225; Hallam K.T., Olver J.S., Norman T.R. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neuropsychopharmacology 2005;30(7):1400–4. DOI:10.1038/sj.npp.1300739; Hanzlik E., Klinger S.A., Carson R., Duis J. Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases. J Clin Sleep Med 2020;16(4):591–5. DOI:10.5664/jcsm.8284; Harlalka G.V., Baple E.L., Cross H. et al. Mutation of HERC2 causes developmental delay with Angelman-like features. J Med Genet 2013;50(2):65–73. DOI:10.1136/jmedgenet-2012-101367; Jan J.E., Freeman R.D. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol 2004;46(11):776–82. DOI:10.1017/s0012162204001331; Larson A.M., Shinnick J.E., Shaaya E.A. et al. Angelman syndrome in adulthood. Am J Med Genet A 2015;167A(2):331–44. DOI:10.1002/ajmg.a.36864; Lipton J., Megerian J.T., Kothare S.V. et al. Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma. Neurology 2009;73(4):323–5. DOI:10.1212/WNL.0b013e3181af78a5; Miano S., Bruni O., Elia M. et al. Sleep breathing and periodic leg movement pattern in Angelman Syndrome: a polysomnographic study. Clin Neurophysiol 2005;116(11):2685–92. DOI:10.1016/j.clinph.2005.08.005; Miano S., Bruni O., Leuzzi V. et al. Sleep polygraphy in Angelman syndrome. Clin Neurophysiol 2004;115(4):938–45. DOI:10.1016/j.clinph.2003.11.004; Morioka N., Sugimoto T., Sato K. et al. The induction of Per1 expression by the combined treatment with glutamate, 5-hydroxytriptamine and dopamine initiates a ripple effect on Bmal1 and Cry1 mRNA expression via the ERK signaling pathway in cultured rat spinal astrocytes. Neurochem Int 2015;90:9–19. DOI:10.1016/j.neuint.2015.06.013; Pelc K., Cheron G., Boyd S.G., Dan B. Are there distinctive sleep problems in Angelman syndrome? Sleep Med 2008;9(4):434–41. DOI:10.1016/j.sleep.2007.07.001; Plante G.E. Sleep and vascular disorders. Metabolism 2006; 55(10 Suppl 2):S45–9. DOI:10.1016/j.metabol.2006.07.013; Ramchandani P., Wiggs L., Webb V., Stores G. A systematic review of treatments for settling problems and night waking in young children. BMJ 2000;320(7229):209–13. DOI:10.1136/bmj.320.7229.209; Ramel J., Bhattachara D., Albalwi S. et al. Effects of clobazam on sleep and daytime function in patients with epilepsy. Sleep 2014;40(1):A433.; Rupa K., Scuteri B., Roberts E. at al. Effect of clonazepam on obstructive sleep apnea coexisting with REM behavior disorder: a case report. Sleep 2019;42(Suppl 1):A413. DOI:10.1093/sleep/zsz069.1024; Ryan C.S., Edlund W., Mandrekar J. et al. Iron deficiency and its role in sleep disruption in patients with Аngelman syndrome. J Child Neurol 2020;35(14):963–9. DOI:10.1177/0883073820941755; Schwichtenberg A.J., Malow B.A. Melatonin treatment in children with developmental disabilities. Sleep Med Clin 2015;10(2):181–7. DOI:10.1016/j.jsmc.2015.02.008; Shi S.Q., Bichell T.J., Ihrie R.A., Johnson C.H. Ube3a imprinting impairs circadian robustness in Angelman syndrome models. Curr Biol 2015;25(5):537–45. DOI:10.1016/j.cub.2014.12.047; Spruyt K., Braam W., Curfs L.M. Sleep in Angelman syndrome: A review of evidence. Sleep Med Rev 2018;37:69–84. DOI:10.1016/j.smrv.2017.01.002; Takaesu Y., Komada Y., Inoue Y. Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients. Sleep Med 2012;13(9):1164–70. DOI:10.1016/j.sleep.2012.06.015; Thase M.E. Depression, sleep, and antidepressants. J Clin Psychiatry 1998;59(Suppl 4):55–65.; Trickett J., Heald M., Oliver C., Richards C. A cross-syndrome cohort comparison of sleep disturbance in children with Smith–Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex. J Neurodev Disord 2018;10(1):9. DOI:10.1186/s11689-018-9226-0; Trickett J., Heald M., Oliver C. Sleep in children with Angelman syndrome: Parental concerns and priorities. Res Dev Disabil 2017;69:105–15. DOI:10.1016/j.ridd.2017.07.017; Trickett J., Oliver C., Heald M. et al. Multi-method assessment of sleep in children with Angelman syndrome: a case-controlled study. Front Psychiatry 2019;10:874. DOI:10.3389/fpsyt.2019.00874; Valente K.D., Andrade J.Q., Grossmann R.M. et al. Angelman syndrome: difficulties in EEG pattern recognition and possible misinterpretations. Epilepsia 2003;44:1051–63.; Williams C.A., Angelman H., Clayton-Smith J. et al. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 1995;56(2):237–8. DOI:10.1002/ajmg.1320560224; Zhdanova I.V., Wurtman R.J., Wagstaff J. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 1999;12(1):57–67. DOI:10.1515/jpem.1999.12.1.57; Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol 2018;175(16):3190–9. DOI:10.1111/bph.14116; https://rjdn.abvpress.ru/jour/article/view/406

  6. 6
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 15, № 3-4 (2020); 78-91 ; Русский журнал детской неврологии; Том 15, № 3-4 (2020); 78-91 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2020-15-3-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/354/240; Beaujard M.P., Jouannic J.M., Bessières B. et al. Prenatal detection of a de novo terminal inverted duplication 4p in a fetus with the Wolf–Hirschhorn syndrome phenotype. Prenat Diagn 2005;25(6):451–5.; Chen C.P., Su Y.N., Chen Y.Y. et al. Wolf–Hirschhorn (4p–) syndrome: prenatal diagnosis, molecular cytogenetic characterization and association with a 1.2-Mb microduplication at 8p22-p21.3 and a 1.1-Mb microduplication at 10p15.3 in a fetus with an apparently pure 4p deletion. Taiwan J Obstet Gynecol 2011;50(4):506–11. DOI:10.1016/j.tjog.2011.10.019.; Hirsch B., Baldinger S. Pericentric inversion of chromosome 4 giving rise to dup(4p) and dup(4q) recombinants within a single kindred. Am J Med Genet 1993;45(1):5–8.; Malvestiti F., Benedicenti F., De Toffol S. et al. Recombinant chromosome 4 from a familial pericentric inversion: prenatal and adulthood wolf-hirschhorn phenotypes. Case Rep Genet 2013;2013:306098. DOI:10.1155/2013/306098.; Paskulin G.A., Riegel M., Cotter P.D. et al. Inv dup del(4) (:p13→p16.3::p16.3→qter) in a girl without typical manifestations of Wolf–Hirschhorn syndrome. Am J Med Genet A 2009;149A(6):1302–7. DOI:10.1002/ajmg.a.32888.; Puig M., Casillas S., Villatoro S., Cáceres M. Human inversions and their functional consequences. Brief Funct Genomics 2015;14(5):369–79. DOI:10.1093/bfgp/elv020.; Stipoljev F., Stanojevic M., Kurjak A. Familial pericentric inversion of chromosome 4: inv(4)(p16.1q12). Clin Genet 2002:61:386–8.; Verrotti A., Carelli A., di Genova L., Striano P. Epilepsy and chromosome 18 abnormalities: A review. Seizure 2015;32:78–8. DOI:10.1016/j.seizure.2015.09.013.; Villa A., Urioste M., Carrascosa M.C. et al. Pericentric inversions of chromosome 4: report of a new family and review of the literature. Clin Genet 1995;48(5):255–60.; Zollino M., Murdolo M., Marangi G. et al. On the nosology and pathogenesis of Wolf–Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review. Am J Clin Genet C 2008;148(4):257–69.; https://rjdn.abvpress.ru/jour/article/view/354

  7. 7
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 16, № 3 (2021); 10-20 ; Русский журнал детской неврологии; Том 16, № 3 (2021); 10-20 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2021-16-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/370/250; Adam M.P., Conta J., Bean L.J.H. Mowat-Wilson Syndrome. In: GeneReviews®. Seattle: University of Washington, 1993-2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1412/.; Adam M.P., Schelley S., Gallagher R. et al. Clinical features and management issues in Mowat-Wilson syndrome. Am J Med Genet A 2006;140:2730-41. DOI:10.1002/ajmg.a.31530.; Bonanni P., Negrin S., Volzone A. et al. Electrical status epilepticus during sleep in Mowat-Wilson syndrome. Brain Dev 2017;39:727-34. DOI:10.1016/j.braindev.2017.04.013.; Bonnard A., Zeidan S., Degas V. et al. Outcomes of Hirschsprung's disease associated with Mowat-Wilson syndrome. J Pediatr Surg 2009;44:587-91. DOI:10.1016/j.jpedsurg.2008.10.066.; Cordelli D.M., Garavelli L., Savasta S. et al. Epilepsy in Mowat-Wilson syndrome: delineation of the electroclinical phenotype. Am J Med Genet A 2013;161A:273-84.; Cui S., Erlichman J., Russo P. et al. Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene ZFHX1B in vertebrate biliary development. J Pediatr Gastroenterol Nutr 2011;52:339-44.; Dastot-Le Moal F., Wilson M., Mowat D. et al. ZFHX1B mutations in patients with Mowat-Wilson syndrome. Hum Mutat 2007;28:313-21.; Deshmukh A.S., Kelkar K.V., Khedkar S.M. et al. Anaesthetic management of Mowat-Wilson syndrome. Indian J Anaesth 2016;60: 292-4. DOI:10.4103/0019-5049.179472.; Evans E., Einfeld S., Mowat D. et al. The behavioral phenotype of Mowat-Wilson syndrome. Am J Med Genet Part A 2012;158A:358-66.; Evans E., Mowat D., Wilson M., Einfeld S. Sleep disturbance in Mowat-Wilson syndrome. Am J Med Genet A 2016;170:654-60.; Garavelli L., Ivanovski I., Caraffi S.G. et al. Neuroimaging findings in Mowat-Wilson syndrome: a study of 54 patients. Genet Med. 2017;19:691-700. DOI:10.1038/gim.2016.176.; Garavelli L., Zollino M., Mainardi P.C. et al. Mowat-Wilson syndrome: facial phenotype changing with age: study of 19 Italian patients and review of the literature. Am J Med Genet A 2009;149A:417-26.; Mowat-Wilson Syndrome. Available at: https://rarediseases.info.nih.gov/diseases/9673/mowat-wilson-syndrome.; Карл II - последний из Габсбургов, или Как кровосмешение привело к вырождению целой династии. Доступно по: https://kulturologia.ru/blogs/181116/32289/.; Ivanovski I., Djuric O., Caraffi S.G. et al. Phenotype and genotype of 87 patients with Mowat-Wilson syndrome and recommendations for care. Genet Med 2018;20:965-75.; Mowat D.R., Croaker G.D., Cass D.T. et al. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet 1998;35:617-23.; Mowat D.R., Wilson M.J. Mowat-Wilson syndrome. In: Management of Genetic Syndromes. New York: John Wiley and Sons, 2010. Pp. 517-529.; Mowat D.R., Wilson M.J., Goossens M. Mowat-Wilson syndrome. J Med Genet 2003;40:305-10.; Niemczyk J., Einfeld S., Mowat D. et al. Incontinence and psychological symptoms in individuals with Mowat-Wilson Syndrome. Res Dev Disabil 2017;62:230-7.; Rogac M., Kitanovski L., Writzl K. Co-occurrence of rhabdomyosarcoma and Mowat-Wilson syndrome: is there a connection? Clin Dysmorphol 2017;26:185-6.; Smigiel R., Szafranska A., Czyzewska M. et al. Severe clinical course of Hirschsprung disease in a Mowat-Wilson syndrome patient. J Appl Genet 2010;51:111-3.; Valera E.T., Ferrza S.T., Brassesco M.S. et al. Mowat-Wilson syndrome: the first report of an association with central nervous system tumors. Childs Nerv Syst 2013;29:2151-5.; Wenger T.L., Harr M., Ricciardi S. et al. CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases. Am J Med Genet A 2014;164A:2557-66. DOI:10.1002/ajmg.a.36696.; https://rjdn.abvpress.ru/jour/article/view/370

  8. 8
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Vol 11, No 1 (2016); 23-28 ; Русский журнал детской неврологии; Vol 11, No 1 (2016); 23-28 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  9. 9
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Vol 10, No 4 (2015); 7-16 ; Русский журнал детской неврологии; Vol 10, No 4 (2015); 7-16 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  10. 10
  11. 11
    Academic Journal

    Συγγραφείς: Mironov M.B.

    Πηγή: Russian Journal of Child Neurology; Vol 9, No 4 (2014); 40-48 ; Русский журнал детской неврологии; Vol 9, No 4 (2014); 40-48 ; 2412-9178 ; 2073-8803

    Περιγραφή αρχείου: application/pdf

  12. 12
  13. 13
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 9, № 3 (2014); 6-12 ; Русский журнал детской неврологии; Том 9, № 3 (2014); 6-12 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2014-9-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/25/21; Карлов В.А. Фармакорезистентность и толерантность при эпилепсии. Журн неврол психиатр 2008;108(10):75–80.; Карлов В.А. Эпилепсия у детей и взрослых женщин и мужчин. Руководство для врачей. М.: Медицина, 2010. 717 с.; Котов А.С., Рудакова И.Г., Мухин К.Ю. и др. Энцефалит Расмуссена. Описание двух клинических случаев. Рус журн дет неврол 2009;4(2):42–50.; Мухин К.Ю., Кваскова Н.Е., Миронов М.Б. и др. Кожевниковская эпилепсия при клещевом русском весенне-летнем энцефалите. Детская больница 2011;2:30–4.; Мухин К.Ю., Миронов М.Б., Кваскова Н.Е. и др. Эпилепсия Кожевникова у детей. Рус журн дет неврол 2006;1(2):19–29.; Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: АртСервис Лтд, 2011. 680 с.; Мухин К.Ю., Пилия С.В., Волкова Э.Ю. и др. Применение высоких доз пирацетама в лечении синдрома кожевниковской эпилепсии. Журн неврол психиатр 2007;107(3):30–6.; Темин П.А., Казанцева Л.З. Наследственные нарушения нервно-психического развития детей: руководство для врачей. М.: Медицина, 2001. 432 с.; Bancaud J., Bonis A., Talairach J. et al. Kojewnikow syndrome and somato-motor attacks (clinical, E.E.G., E.M.G. and S.E.E.G. study). Encephale 1970;59(5):391–438.; Bien C.G., Elger C.E. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 2008;10(1): 3–7.; Bulteau C., Otsuki T., Delalande O. Epilepsy surgery for hemispheric syndromes in infants: hemimegalencepahly and hemispheric cortical dysplasia. Brain Dev 2013;35(8):742–7.; Caraballo R.H., Fortini S., Cersosimo R. et al. Rasmussen syndrome: an Argentinean experience in 32 patients. Seizure 2013;22(5):360–7.; Caviness J.N. Treatment of myoclonus. Neurotherapeutics 2014;11(1):188–200.; Cockerell O.C., Rothwell J., Thompson P.D. et al. Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK.; Engel J. Jr. Report of the ILAE сlassification сore group. Epilepsia 2006;47(9):1558–68.; Engel J. Jr.; International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796–803.; Fattouch J., Di Bonaventura C., Di Gennaro G. et al. Electrical status epilepticus "invisible" to surface EEG in late-onset Rasmussen encephalitis. Epileptic Disord 2008;10(3):219–22.; Granata T., Andermann F. Rasmussen encephalitis. Handb Clin Neurol 2013;111:511–9.; Guerrini R., Takahashi T. Myoclonus and epilepsy. Handb Clin Neurol 2013;111:667–79.; Hamad A.P., Caboclo L.O., Centeno R. еt al. Hemispheric surgery for refractory epilepsy in children and adolescents: outcome regarding seizures, motor skills and adaptive function. Seizure 2013;22(9):752–6.; Honda R., Kaido T., Sugai K. еt al. Longterm developmental outcome after early hemispherotomy for hemimegalencephaly in infants with epileptic encephalopathy. Epilepsy Behav 2013;29(1):30–5.; Honda R., Saito Y., Nakagawa E. еt al. Focal cortical myoclonus in rolandic cortical dysplasia presenting as hemifacial twitching. Brain Dev 2012;34(10): 886–90.; Kojovic M., Cordivari C., Bhatia K. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord 2011;4(1):47–62.; Korman B., Krsek P., Duchowny M. et al. Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks. Neurology 2013;81(8):745–51.; Mameniskiene R., Bast T., Bentes C. et al. Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsiapartialis continua: a European survey and analysis of 65 cases. Epilepsia 2011;52(6):1168–76.; Molyneux P.D., Barker R.A., Thom M. et al. Successful treatment of intractable epilepsia partialis continua with multiple subpial transections. J Neurol Neurosurg Psychiatry 1998;65(1):137–8.; Mukhin K.Y., Mameniskienė R., Mironov M.B. et аl. Epilepsia partialis continua in tick-borne Russian spring-summer encephalitis. Acta Neurol Scand 2012;125(5):345–52.; Myoclonus and epilepsy in childhood Commission on Pediatric Epilepsy of the International League Against Epilepsy. Epilepsia 1997;38(11):1251–4.; Myoclonus and epilepsy. In: Epilepsy and movement disorders. R. Gueririni, J. Aicardi, F. Anderman et al. (eds.). Cambridge: University Press, 2002. Рр. 165–210.; Obeso J.A. Classification, clinical features and treatment of myoclonus. In: Movement Disorders. Neurologic principles and practice. R.L. Watts, W.C. Koller (eds.). New York: McGraw-Hill, 1997. Pp. 541–50.; Paiboonpol S. Epilepsia partialis continua as a manifestation of hyperglycemia. J Med Assoc Thai 2005;88(6):759–62.; Panayiotopoulos С.P. A сlinical guide to epileptic syndromes and their treatment. 2nd ed. London: Springer Ltd, 2010. 654 p.; Panayiotopoulos C.P. The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician's critical view and contribution. Epilepsia 2011;52(12): 2155–60.; Panayiotopoulos C.P. The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 2012;53(3):399–404.; Perez-Jimenez A., Garcia-Fernandez M., Santiago Mdel M., Fournier-Del Castillo MC. Video electroencephalographic diagnosis of epileptic and non-epileptic paroxysmal episodes in infants and children at the pre-school age. Rev Neurol 2012;54 Suppl 3:S59–66.; Proposal for classification of epilepsies and epileptic syndrome Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30(4):389–99.; Riqueta A., Auvina S., Cuisseta J.M. еt al. Epilepsia partialis continua and defects in the mitochondrial respiratory chain. Epilepsy Res 2008:78(1):1–6.; Shain C., Ramgopal S., Fallil Z. еt al.; EPGP Investigators. Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project. Epilepsia 2013;54(8):1368–75.; So N.K., Gloor P. Electroencephalographic and electrocorticographic findings in chronic encephalitis of the Rasmussen type. In: Chronic encephalitis and epilepsy: Rasmussen’s syndrome. F. Andermann (ed.). Boston: Butterworth-Heinemann, 1991. 3745 р.; Spalletti M., Comanducci A., Vagaggini A. еt al. Efficacy of lacosamide on seizures and myoclonus in a patient with epilepsia partialis continua. Epileptic Disord 2013;15(2):193–6.; Walker M.C., Schorge S., Kullmann D.M. еt al. Gene therapy in status epilepticus. Epilepsia 2013;54 Suppl 6:43–5.; Wang B., Cai F.C. Polyneuroelectrophysiological studies of myoclonus in children. Zhonghua Er Ke Za Zhi 2009;47(10):750–6.; https://rjdn.abvpress.ru/jour/article/view/25

  14. 14
    Academic Journal

    Πηγή: Russian Journal of Child Neurology; Том 10, № 3 (2015); 48-54 ; Русский журнал детской неврологии; Том 10, № 3 (2015); 48-54 ; 2412-9178 ; 2073-8803 ; 10.17650/2073-8803-2015-10-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://rjdn.abvpress.ru/jour/article/view/109/100; Башина В.М. Аутизм в детстве. М.: Медицина, 1999. 240 с. [Bashina V.M. Autism in childhood. Moscow: Meditsina, 1999. 240 p. (In Russ.)].; Бобылова М.Ю., Печатникова Н.Л. Генетика аутизма (обзор зарубежной литературы). Русский журнал детской неврологии 2013;8(3):31–45. [Bobylova M.Yu., Pechatnikova N.L. Genetics of autism (review of foreign references). Russkiy zhurnal detskoy nevrologii = Russian Journal of Pediatric Neurology 2013;8(3):31–45. (In Russ.)].; Зверева Н.В., Горячева Т.Г. Клиническая психология детей и подростков. М.: Издательский центр «Академия», 2013. 272 с. [Zvereva N.V., Goryacheva T.G. Clinical psychology of children and adolescents. Moscow: Academy Publishing Center, 2013. 272 p. (In Russ.)].; Международная статистическая классификация болезней и проблем, связанных со здоровьем, 10-й пересмотр. Всемирная организация здравоохранения, Женева, 1995. [International statistical classification of diseases and problems related to health, 10th ed. World Health Organization, Geneva, 1995. (In Russ.)].; Миронов М.Б. Эпилептический миоклонус век (лекция). Русский журнал детской неврологии 2010;5(4):29–38. [Mironov M.B. Epileptic myoclonus of the eyelids. Russkiy zhurnal detskoy nevrologii = Russian Journal of Pediatric Neurology 2010;5(4):29–38. (In Russ.)].; Миронов М.Б., Мухин К.Ю. Атипичные абсансы – распространенность, электроклинические и нейровизуализационные характеристики. Журнал неврологии и психиатрии им. С.С. Корсакова 2012;112(6–2):18–26. [Mironov M.B., Mukhin K.Yu. Atypical absence seizures: prevalence, electrical clinical and neuroimaging characteristics. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatrics 2012;112(6–2):18–26. (In Russ.)].; Мухин К.Ю. Когнитивная эпилептиформная дезинтеграция: дефиниция, диагностика, терапия. Русский журнал детской неврологии 2012;7(1):3–20. [Mukhin K.Yu. Cognitive epileptiform disintegration: definition, diagnostics, therapy. Russkiy zhurnal detskoy nevrologii = Russian Journal of Pediatric Neurology 2012;7(1):3–20. (In Russ.)].; Мухин К.Ю. Эпилептические энцефалопатии при наследственных заболеваниях и хромосомных аномалиях. В кн.: Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: АртСервис Лтд, 2011. С. 427–547. [Mukhin K.Yu. Epileptic encephalopathy with hereditary diseases and chromosomal anomalies. In: Mukhin K.Yu., Petrukhin A.S., Kholin A.A. Epileptic encephalopathy and similar syndromes of children. Moscow: ArtService Ltd., 2011. Pp. 427–547. (In Russ.)].; Мухин К.Ю., Миронов М.Б., Петрухин А.С. Эпилептические синдромы. Диагностика и терапия. Руководство для врачей. М.: Системные решения, 2014. 376 с. [Mukhin K.Yu., Mironov M.B., Petrukhin A.S. Epileptic syndromes. Diagnostics and therapy. Manual for; physicians. Moscow: Sistemnye resheniya, 2014. 376 p. (In Russ.)].; Расстройства аутистического спектра у детей. Научно-практическое руководство. Под ред. Н.В. Симашковой. М.: Авторская академия, 2013. 264 с. [Autism spectrum disorders of children. Research and practical manual. Ed by: N.V. Simashkova. Moscow: Avtorskaya Akademiya, 2013. 264 p. (In Russ.)].; Тиганов А.С., Башина В.М. Современные подходы к пониманию аутизма в детстве. Журнал неврологии и психиатрии 2005; 105(8):4–13. [Tiganov A.S., Bashina V.M. Modern approaches to understanding of autism in childhood. Zhurnal nevrologii i psikhiatrii = Journal of Neurology and Psychiatrics 2005;105(8):4–13. (In Russ.)].; Ремшмидт Х. Аутизм. Клинические проявления, причины и лечение. М.: Медицина, 2003. 120 с. [Remschmidt H. Autism. Clinical phenomena, reasons, and treatment. Moscow: Meditsina, 2003. 120 p. (In Russ.)].; Asperger H. Die “Autistischen Psychopathen” im Kindesalter. Arch Psychiatr Nervenkrank 1944;117:76–136.; Berryer M.H., Hamdan F.F., Klitten L. et al. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haplo insufficiency. Hum Mutat 2013;34:385–94.; Bleuler E. Dementia praecox oder gruppe der schizophrenien. Leipzig und Wien: Franz Deuticke, 1911.; Carvill G.L., Heavin S.B., Yendle S.C. et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45:825–30.; Clement J.P., Aceti M., Creson T.K. et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 2012;151:709–23.; Hamdan F.F., Daoud H., Piton A. et al. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiat 2011;69: 898–901.; Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217–50.; Klitten L.L., Moller R.S., Nikanorova M. et al. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 2011;52(12):190–3.; OMIM (Online Mendelian Inheritance in Man). An online catalog of human genes and genetic disorders. http://www.omim.org/entry/603384.; Rauch A., Hoyer J., Guth S. et al. Diagnostic yield of various genetic аpproaches in рatients with unexplained developmental delay or mental retardation. Am J Med Genet A 2006;140(19): 2063–74.; Writzl K., Knegt A.C. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment. Am J Med Genet A 2013;161A(7):1682–5.; Zollino M., Gurrieri F., Orteschi D. et al. Integrated analysis of clinical signs and literature data for the diagnosis and therapy of a previously undescribed 6p21.3 deletion syndrome. Eur J Hum Genet 2011;19(2): 239–42.; https://rjdn.abvpress.ru/jour/article/view/109

  15. 15
  16. 16
  17. 17
  18. 18